Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity.
about
Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in micePhase and antigenic variation in bacteriaFunctional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis.Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial.The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype specific?Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine.Cross-reactive polyclonal antibodies to the inner core of lipopolysaccharide from Neisseria meningitidis.Lipooligosaccharide structure contributes to multiple steps in the virulence of Neisseria meningitidis.Measurement of functional anti-meningococcal serogroup a activity using strain 3125 as the target strain for serum bactericidal assay.Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccineBactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines.Two glycosyltransferase genes, lgtF and rfaK, constitute the lipooligosaccharide ice (inner core extension) biosynthesis operon of Neisseria meningitidis.Analysis of the bactericidal response to an experimental Neisseria meningitidis vesicle vaccineComparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis Group B isolates in a serum bactericidal antibody assayA comparison of the endotoxin biosynthesis and protein oxidation pathways in the biogenesis of the outer membrane of Escherichia coli and Neisseria meningitidis.Phase-variable expression of lipopolysaccharide contributes to the virulence of legionella pneumophila.Galectin-3 binds Neisseria meningitidis and increases interaction with phagocytic cells.Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response.Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidisRole of lipopolysaccharide sialylation in serum resistance of serogroup B and C meningococcal disease isolates.Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunization with an outer membrane vaccine.Influence of the length of the lipooligosaccharide alpha chain on its sialylation in Neisseria meningitidisExpression of sialic acid and polysialic acid in serogroup B Neisseria meningitidis: divergent transcription of biosynthesis and transport operons through a common promoter region.Intranasal delivery of group B meningococcal native outer membrane vesicle vaccine induces local mucosal and serum bactericidal antibody responses in rabbitsCharacterization of an antibody depletion assay for analysis of bactericidal antibody specificity.Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccinationThe development of an experimental multiple serogroups vaccine for Neisseria meningitidis.
P2860
Q24548847-4660C993-BD33-491E-A0B1-E7F090A447E5Q24561666-BDFD8BFC-B2B9-4BE6-BDF0-BDCD1DE8AA94Q30175865-69FA883C-E039-411D-8B3A-2173C967BF19Q33756300-6DC54950-5285-4060-94E9-BE56B9606DAAQ33769638-894696FA-0803-44CD-9FEC-C8B5126FED41Q33998397-64E46980-2126-4BC8-B3AF-93104600F06CQ34116994-213F23A0-4EA8-430A-9797-631E9D500A3EQ34119002-18067C2E-FDAF-49B9-A468-A78DA8BDE1D0Q34334420-C3FB1687-898F-42EB-94CC-48E6AC40F830Q35138700-69B6AA7A-7215-470E-9477-BF29E2582A08Q35229074-DD45C5CE-7881-45DF-B1B5-576A6EB8B402Q35454550-7D9410AC-9503-45CB-812A-1C4F220BDFF8Q35544353-ED2F8770-A09D-428B-B611-6ABC19453800Q35617191-EEBBE5A0-220F-4BC1-9CAD-F834D2BE883FQ35940761-96D54407-5A2F-4A13-90B5-7BC3D9040C57Q36313615-841FB473-6851-47CB-B41D-CA712DE4906FQ36479175-2E9FF110-59A2-4E34-A06E-6E3B93F74718Q36851737-295188AE-53C7-4099-9398-54B193AD669AQ37111813-27E3CA78-587B-4C6A-8C6C-D2E9C0333363Q37191328-606051C9-8FAA-4B87-A3CE-7D7F209266F2Q38342684-43AFCF22-6D6E-48D2-B57F-9B025C2FC5CBQ39509812-FF6F63A9-A2F9-4003-8C54-215693D37975Q39573174-CADCB02A-2235-4617-9BCB-30BE197B00A9Q39653693-72315C44-C2DB-40A9-883C-3849F6B8AC62Q39841939-B0C75C36-CEFD-49E2-9AD2-A79FCD339130Q40502872-4644666B-CDD9-4B2B-BD6E-6A3E76BFFDE4Q41774048-446686E3-262F-4EF1-B218-6212D56893AFQ42000280-D604AF6D-D79B-45CB-AA19-FAF86145C741Q42131377-2D4650EC-EBF9-4756-984D-D50540AC33EC
P2860
Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity.
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Expression of the L8 lipopolys ...... o serum bactericidal activity.
@ast
Expression of the L8 lipopolys ...... o serum bactericidal activity.
@en
Expression of the L8 lipopolys ...... o serum bactericidal activity.
@nl
type
label
Expression of the L8 lipopolys ...... o serum bactericidal activity.
@ast
Expression of the L8 lipopolys ...... o serum bactericidal activity.
@en
Expression of the L8 lipopolys ...... o serum bactericidal activity.
@nl
prefLabel
Expression of the L8 lipopolys ...... o serum bactericidal activity.
@ast
Expression of the L8 lipopolys ...... o serum bactericidal activity.
@en
Expression of the L8 lipopolys ...... o serum bactericidal activity.
@nl
P2093
P2860
P1476
Expression of the L8 lipopolys ...... o serum bactericidal activity.
@en
P2093
P2860
P304
P407
P577
1994-12-01T00:00:00Z